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The effect of interleukin-lfl (IL-I) on expression ofc-fos mRNA in isolated rat pancreatic islets was examined. Accumulation ofc-fos mRNA 
was demonstrable after 30 min of exposure to IL-1, peaked by 60 min, and declined thereafter. Fluorescence-activated cell sorting (FACS) of 
dispersed islet cells was employed tolocalize the accumulation f c-fos mRNA to the fl-cell. Cycloheximide id not influence the induction of c-fos 
mRNA by IL-1. Accumulation ofc-fos mRNA therefore appears to be an early signal transduction event in the fl-cell and a component ofthe 
cellular mechanism(s) by which IL-1 influences fl-cell function. 
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1. INTRODUCTION 
An impressive body of evidence suggests that the 
disease insulin-dependent diabetes mellitus (IDDM) has 
an underlying autoimmune component [1]. Although 
the molecular mechanisms which contribute to the 
pathogenesis of IDDM are not yet understood, a recent 
hypothesis is that the soluble immune mediator, in- 
terleukin 1 (IL-1), plays a role in the destruction of pan- 
creatic d-cells that is the hallmark pathologic lesion of 
the disease [2]. IL-1, alone or in concert with other 
cytokines, has been reported to cause lysis of d-cells in 
vitro under some conditions [3-6]. In addition, IL-1 ex- 
erts potent stimulatory and inhibitory effects on insulin 
secretion from isolated islets under conditions in which 
cell viability is maintained [7-12]. These latter effects of 
IL-1 on islets have been taken to imply that IL-1 may 
play a physiologic role in the modulation of insulin 
secretion [8,11]. 
Although disruptions in mitochondrial function 
[9,13-15] and the generation of toxic-free radicals 
[16,17] have been proposed to contribute to the func- 
tional effects of IL-1 on islets, the molecular mecha- 
nisms whereby IL-1 exerts its complex effects on insulin 
secretion and d-cell viability are largely unknown. The 
recent demonstration that/%cells possess pecific recep- 
tors for IL-1 suggests that some or all of  the effects of 
IL-1 on the/~-cell may be the result of  specific receptor- 
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mediated pathways [18]. Little is known about the 
mechanism of action of IL-1 following binding of the 
cytokine to its receptor, but the observation that IL-1 
and its receptor are translocated to the nucleus in the 
murine T cell line EL-4 indicates that IL-1 may directly 
modulate the transcription of specific genes in target 
cells [19]. Helqvist has demonstrated that IL-1 induces 
protein synthesis in isolated islets [20], and we have 
recently demonstrated that inhibition of insulin secre- 
tion by IL-1 is prevented by an inhibitor of gene tran- 
scription (actinomycin D) [21]. These findings under- 
score the potential importance of new gene products in 
the functional effects of IL-1 on the/Y-cell. 
The identities of specific genes whose expression is 
modulated by IL-1 in the d-cell have not yet been deter- 
mined, but a great deal of recent attention has been 
focused on the early response genes that are activated 
by IL-1 in other cells and on the roles that the protein 
products of these genes play in the biological effects of 
the cytokine. In fibroblasts and in endothelial cells, 
IL-1 induces rapid, transient expression of the c-fos 
proto-oncogene [22,23]. The protein product of the c- 
fos gene (c-Fos) has been proposed to function as a 
transcriptional regulator which couples early signal 
transduction events to long-term nuclear events that 
result in growth, differentiation, or the acquisition of 
new functional properties by the target cell [24,25]. 
In this study, the effect of IL-1 on c-fos mRNA ex- 
pression has been examined in pancreatic islets isolated 
from rats. Our results indicate that c-fos mRNA is 
rapidly induced in isolated islets and in purified d-cells 
by IL-1, and they suggest hat IL-1 has the capacity of 
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initiate nuclear events which may be involved in the 
functional effects of IL-1 on insulin secretion. 
EFFECT OF IL-1 ON EXPRESSION OF C-FOS mRNA 
IN ISOLATED RAT ISLETS 
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2. MATERIALS AND METHODS 
2.1. Isolation of  rat islets and purification of  islet ~-cells by 
autofluorescence-activated cell sorting 
Islets were isolated from 12-15 rats fed ad libitum by collagenase 
digestion, as previously described [26]. Isolated islets were dispersed 
into individual cells by treatment with dispase, and the freshly 
dissociated cells were subjected to autofluorescence-activated cell 
sorting (FACS) using a FACS-IV instrument [27,28]. An argon laser 
illuminated the cells at 488 nm, and emission was monitored at 
510-550 nm. This technique yields two populations of cells. One 
population consists of highly purified fl-cells (>90°70). The second 
population is predominantly a-cells (7007o) but also contains ome t~- 
cells and a few #-cells [27,28]. 
Fig. 1. Effect of IL-1 on expression of c-fos in isolated pancreatic 
islets. Isolated rat islets were incubated in CMRL-1066 tissue culture 
medium containing IL-I (5 U/ml) for 0 min (lane 1), 30 rain (lane 2), 
60 min (lane 3), 90 min (lane 4), 2 h (lane 5), 4 h (lane 6), or 8 h (lane 
7). Northern analysis for c-fos was then performed as described in sec- 
tion 2. Total RNA isolated from PC-12 rat pheochromocytoma cells 
stimulated with nerve growth factor served as a positive control for c- 
fos expression (lane 8). 
2.2. Incubation of  isolated islets and FACS-purified islet cells 
with IL-1 
Isolated islets and FACS-purified islets cells were placed in 2.5 ml 
Petri dishes containing CMRL-1066 tissue culture medium with 
recombinant human interleukin-l# (Cistron, Pine Brook, NJ) 
(5U/ml) or the control vehicle. Either 600 islets/dish or 5x 10 ~ 
dispersed, purified cells/dish were used. In some experiments, 
cycloheximide (10/~M) was added. The dishes were incubated at 37°C 
under an atmosphere of 95070 air/5070 CO2 for a predetermined time 
interval. At the end of this interval, the islets or FACS-purified cells 
were harvested, placed in 1.5 ml microcentrifuge tubes, and centrifug- 
ed in a table-top microcentrifuge for 15 s. The supernatant was 
discarded, and 500 ml guanidine isothiocyanate was added. Isolation 
of RNA and Northern blot analysis were then performed as described 
[29]. Total cellular RNA isolated from PC-12 rat pheochromocytoma 
cells stimulated with nerve growth factor served as a positive control 
for c-fos expression [29]. 
3. RESULTS 
IL-1 was found to induce rapid, transient accumula- 
tion of c-fos mRNA in isolated rat islets (Fig. 1). The c- 
fos mRNA was not detected in untreated islets (lane 1), 
but detectable l vels were achieved after 30 min of ex- 
posure to IL-1 (lane 2). Accumulation of c-los mRNA 
was maximal after 60 min of exposure to IL-1 (lane 3) 
and declined rapidly thereafter (lanes 4-7). 
The islet is a heterogeneous cell population which 
contains a variety of endocrine cells, each of which 
represents a potential target for IL-1. In order to 
localize the accumulation of c-fos mRNA to the f?-cell 
and to demonstrate hat the induction of c-fos mRNA 
does not require the presence of non #-cells, we examin- 
ed the effect of IL-1 on the accumulation of c-fos 
mRNA in islet cells which had been purified by 
fluorescence-activated cell sorting (FACS). Fig. 2 
demonstrates that IL-1-induced c-fos mRNA accumula- 
tion in intact isolated islets (lanes 1 and 2) and in FACS- 
purified ~'-cells (lanes 3 and 4) but not in FACS-purified 
a-cells (lanes 5 and 6). This finding suggests that IL-1 
induces c-fos expression by a direct effect on the H-cell, 
rather than by an action on an intermediary cell. 
A characteristic feature of c-fos and other 'imme- 
diate-early' response genes is that their induction by 
growth factors or differentiation-inducing agents oc- 
curs under conditions where protein synthesis is in- 
hibited [32]. These 'immediate-early' response genes 
therefore appear to be directly coupled to signal 
transduction events, and their expression does not re- 
quire the synthesis of transcription-activating proteins. 
In order to examine what role protein synthesis plays in 
the induction of c-fos by IL-1, isolated rat islets were 
cultured with either IL-1 (5 U/ml) or with vehicle in the 
presence or absence of cycloheximide (10/~M) for 1 h. 
At this concentration, cycloheximide completely in- 
hibited islet protein synthesis, as assessed by the incor- 
poration of [~SS]methionine into total islet TCA- 
precipitable protein (not shown). Total islet RNA was 
isolated, and Northern analysis was performed as 
described above in section 2. Fig. 3 demonstrates that 
cycloheximide had no effect on the accumulation of c- 
fos mRNA induced by IL-1 (lanes 2 and 4). This finding 
suggests that IL-l-induced accumulation of c-fos 
mRNA does not require intermediary protein synthesis, 
and it is consistent with a role for c-fos as an 'imme- 
diate-early' gene in the response of the ~?-cell to IL-1. 
Cycloheximide alone induced c-fos to a small degree 
(lane 3). This may reflect hat c-fos transcription is con- 
trolled by a suppressor protein whose synthesis i block- 
EFFECT OF IL-1 ON EXPRESSION OF C-FOS mRNA 
iN FACS-PURIFIED ISLET CELLS 
1 2 3 4 5 6 
Fig. 2. Effect of IL-1 on expression of c-fos mRNA in FACS-purified 
islet cells. Isolated rat islets (lanes 1 and 2), a FACS-purified islet cell 
population enriched for B-cells (lanes 3 and 4), and a FACS-purified 
islet cell population enriched for a-cells (lanes 5 and 6) were treated 
with vehicle (odd-numbered lanes) or with IL-I (5 U/ml) (even- 
numbered lanes) for 60 min. Northern analysis for c-fos was then per- 
formed as described in section 2. 
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EFFECT OF CYCLOHEXIMIDE ON IL-I-INDUCED EXPRESSION 
OF C-FOS mRNA IN ISOLATED RAT ISLETS 
1 2 3 4 5 
Fig. 3. Effect of cycloheximide on IL-l-induced expression of c-fos 
mRNA in isolated rat islets. Isolated islets were treated with vehicle 
(lane 1), IL-1 (5 U/ml) (lane 2), cycloheximide (10/~M) (lane 3), or 
IL-I + cycloheximide (lane 4) for 60 min. Northern analysis for c-fos 
mRNA was then performed as described in section 2.. Total RNA 
isolated from PC-12 rat pheochromocytoma cells stimulated with 
nerve growth factor served as a positive control for c-fos expression 
(lane 5). 
ed by cycloheximide or that cycloheximide stabilizes the 
c-fos transcripts by blocking the synthesis of enzymes 
involved in mRNA degradation. 
4. DISCUSSION 
The c-fos proto-oncogene is a member of the class of 
inducible genes termed 'immediate-early' genes [30-32]. 
The protein product of the c-fos gene is thought o 
function as a transcriptional regulator which couples 
extracellular signals to alterations incellular phenotype 
by regulating the expression of target genes [30,31]. In- 
duction of c-fos occurs in response to many growth fac- 
tors and differentiation-inducing agents [24,25]. For ex- 
ample, c-fos expression has been associated with the 
transition from Go to G1 that occurs when quiescent 
fibroblasts are stimulated with epidermal growth factor 
[24,25]. In addition, c-fos is thought to play a role in the 
functional response of macrophages to colony sti- 
mulating factors [24,25] and in the prolonged func- 
tional changes induced in neurons by nerve growth fac- 
tor and neurotransmitters [32]. In this study we have 
provided the first demonstration that IL-1 induces ac- 
cumulation of c-fos mRNA both in isolated pancreatic 
islets and in FACS-purified pancreatic B-cells. Our 
results indicate that induction of c-fos mRNA ac- 
cumulation occurs through a direct interaction of IL-1 
with the B-cells and does not require the synthesis of 
protein(s). The latter finding suggests that the c-fos 
gene product may directly couple early transmembrane 
signals to long-term nuclear esponses which influence 
islet function. 
The precise role that induction of c-fos plays in the 
functional effects of IL-1 on the B-cell has not yet been 
established. Our recent demonstration that a phar- 
macologic inhibitor of mRNA synthesis (actinomycin 
D) prevents the inhibition of insulin secretion otherwise 
induced by IL-1 suggests that II-l-induced gene 
transcription is required for the development of the ef- 
fects of IL-1 on insulin secretion from pancreatic slet B- 
cells [21]. It is therefore possible that the protein prod- 
uct of the c-fos gene (c-Fos) regulates the expression of 
genes whose products mediate the inhibitory influence 
of IL-1 on insulin secretion. It is also possible that c-Fos 
induces the transcription of specific genes whose prod- 
ucts are involved in the reported cytotoxic effects of 
IL-1 on the B-cell [3-6]. Recently, Helqvist demon- 
strated that IL-1 induces the synthesis of several pro- 
teins in islets [20]. The identities of these proteins have 
not yet been determined, but the observation that IL-1 
induces new protein synthesis in islets underscores the 
potential importance of specific gene products as 
mediators of IL-1 action. Identification of the B-cell 
gene(s) whose transcription is regulated by the c-fos 
gene product will lead to a better understanding of the 
mechanism ofaction of IL-1 on theB-cell and may yield 
insight into the pathogenesis of IDDM. 
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